サル痘治療の世界市場レポート 2025年

サル痘治療の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR13.3％で1億7,000万米ドルに成長します。予測期間の成長は、グローバリゼーションと旅行、政府の資金援助と支援、バイオテクノロジーと製薬への投資、公衆衛生モニタリング、規制当局の承認に起因すると考えられます。予測期間の主要動向には、抗ウイルス薬開発、天然痘ワクチンの使用、モノクローナル抗体、併用療法、長期免疫研究などがあります。

サル痘（mpox）治療市場は、人獣共通感染症の流行の高まりにより拡大が見込まれています。人獣共通感染症とは、汚染された環境や媒介動物との直接的な接触を通じて動物からヒトに移る病気です。人と動物の相互作用が増加し、人と動物がより近接するようになると、人獣共通感染症のリスクが高まります。さらに気候変動は、病原体を媒介する動物の範囲を拡大し、新たな地域に病原体を持ち込むことで、このリスクを悪化させています。サル痘の治療は、人獣共通感染症であるmpoxウイルスを管理し、ヒトと感染した可能性のある動物の両方の症状を緩和するように設計されています。例えば、2024年8月に英国健康安全保障局から発表された報告によると、英国では3,732例の痘瘡が確認されており、2023年の3,753例から増加しています。このように人獣共通感染症の流行が拡大していることが、サル痘治療に対する需要を促進しています。

サル痘治療市場の企業は、アクセシビリティの向上、患者管理の合理化、治療成績の向上を目的として、バーチャルケアなどの遠隔モニタリングや遠隔治療ソリューションに注力しています。サル痘のバーチャルケアは、遠隔診療、症状評価、リスクや感染者の管理戦略を含むため、ケアへのアクセスが容易になり、対面診療の必要性が減少します。例えば、米国を拠点とする医療企業Folx Healthは、2022年8月、サル痘のリスクや罹患者のためのバーチャルプライマリーケアサービスであるMonkeypox Careを開始しました。このサービスは、教育、カウンセリング、症状評価、発表を提供するもので、医療アクセスが限られている恵まれない地域の個人を対象としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、新型コロナウイルス感染症、景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のサル痘治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のサル痘治療市場：成長率分析
• 世界のサル痘治療市場の実績：規模と成長、2019～2024年
• 世界のサル痘治療市場の予測：規模と成長、2024～2029年、2034年
• 世界のサル痘治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のサル痘治療市場：治療タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 予防ワクチン
• 治療
• 世界のサル痘治療市場：剤形別、実績と予測、2019～2024年、2024～2029年、2034年
• 固体
• 液体
• 半固体
• 世界のサル痘治療市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口
• 局所
• 非経口
• 世界のサル痘治療市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 小売薬局
• 病院薬局
• オンライン薬局
• 世界のサル痘治療市場、予防ワクチンのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ワクシニアベースのワクチン
• 弱毒化ワクシニアアンカラ（MVA）ワクチン
• その他のワクチン（組み換えワクチン）
• 世界のサル痘治療市場、治療剤のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 抗ウイルス剤（テコビリマット、ブリンシドフォビル）
• 免疫調節薬
• 支持療法による治療

第7章 地域別・国別分析

• 世界のサル痘治療市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のサル痘治療市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• サル痘治療市場：競合情勢
• サル痘治療市場：企業プロファイル
  • Roche Holding AG
  • Merck & Co. Inc.
  • Sanofi S.A.
  • Gilead Sciences Inc.
  • BioNTech SE

第31章 その他の大手企業と革新的企業

• Moderna Inc.
• Quest Diagnostics Incorporated
• Novavax Inc.
• Laboratory Corporation of America Holdings
• Emergent BioSolutions Inc.
• Bavarian Nordic A/S
• Aegis Sciences Corporation
• Daan Gene Co. Ltd.
• Sansure BIoTech Inc.
• SIGA Technologies Inc.
• Elabscience BIoTechnology Inc.
• Mayo Clinic Laboratories
• Tonix Pharmaceuticals Holding Corp.
• Altona Diagnostics GmbH
• Lansion BIoTechnology Co. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• サル痘治療市場、2029年：新たな機会を提供する国
• サル痘治療市場、2029年：新たな機会を提供するセグメント
• サル痘治療市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Monkeypox treatment involves medical interventions and therapies designed to manage and alleviate the symptoms of monkeypox, a viral disease caused by the monkeypox virus. These treatments include various therapeutic and supportive approaches aimed at reducing disease severity and enhancing patient outcomes.

The primary types of monkeypox treatment are prophylactic vaccines and therapeutics. Prophylactic vaccines are intended to prevent monkeypox infection by boosting the immune system to recognize and combat the virus, particularly in high-risk populations and during outbreaks to limit the virus's spread. Treatment dosage forms include solid, liquid, and semisolid, with administration routes such as oral, topical, and parenteral. These treatments are distributed through retail pharmacies, hospital pharmacies, and online pharmacies.

The monkey pox treatment market research report is one of a series of new reports from the business research company that provides monkey pox treatment market statistics, including monkey pox treatment industry global market size, regional shares, competitors with an monkey pox treatment market share, detailed monkey pox treatment market segments, market trends and opportunities, and any further data you may need to thrive in the monkey pox treatment industry. This monkey pox treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The monkey pox treatment market size has grown rapidly in recent years. It will grow from $0.09 billion in 2024 to $0.1 billion in 2025 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to outbreaks in endemic regions, zoonotic transmission awareness, smallpox eradication legacy, public health initiatives, emergence of human cases.

The monkey pox treatment market size is expected to see rapid growth in the next few years. It will grow to $0.17 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to globalization and travel, government funding and support, biotech and pharmaceutical investment, public health surveillance, and regulatory approvals. Major trends in the forecast period include antiviral drug development, use of smallpox vaccines, monoclonal antibodies, combination therapies, and long-term immunity research.

The monkeypox (mpox) treatment market is expected to expand due to the rising prevalence of zoonotic infections. Zoonotic infections are diseases that transfer from animals to humans through direct contact with contaminated environments or vectors. Increased human-animal interaction, which brings people and animals into closer proximity, heightens the risk of zoonotic infections. Additionally, climate change exacerbates this risk by expanding the range of disease vectors and introducing pathogens to new regions. Treatments for monkeypox are designed to manage the zoonotic mpox virus and alleviate symptoms in both humans and potentially infected animals. For example, a report from the UK Health Security Agency in August 2024 indicated 3,732 confirmed cases of mpox in the UK, an increase from 3,753 cases in 2023. This growing prevalence of zoonotic infections is driving demand for monkeypox treatments.

Companies in the monkeypox treatment market are focusing on remote monitoring and teletherapy solutions, such as virtual care, to improve accessibility, streamline patient management, and enhance treatment outcomes. Virtual care for monkeypox involves remote medical consultations, symptom evaluation, and management strategies for individuals at risk or infected, thus facilitating access to care and reducing the need for in-person visits. For instance, in August 2022, Folx Health, a US-based healthcare company, launched Monkeypox Care, a virtual primary care service for those at risk of or affected by monkeypox. This service offers education, counseling, symptom evaluation, and referrals, aiming to reach individuals in underserved areas with limited healthcare access.

In August 2024, Bilthoven Biologicals, a Netherlands-based provider of vaccines and biopharmaceuticals, entered into a partnership with Tonix Pharmaceuticals. The collaboration is focused on accelerating the development of TNX-801, a potential vaccine for preventing mpox, smallpox, and other infectious diseases. Tonix Pharmaceuticals, a US-based pharmaceutical company, is engaged in developing vaccines for monkeypox treatment.

Major companies operating in the monkey pox treatment market are Roche Holding AG, Merck & Co. Inc., Sanofi S.A., Gilead Sciences Inc., BioNTech SE, Moderna Inc., Quest Diagnostics Incorporated, Novavax Inc., Laboratory Corporation of America Holdings, Emergent BioSolutions Inc., Bavarian Nordic A/S, Aegis Sciences Corporation, Daan Gene Co. Ltd., Sansure Biotech Inc., SIGA Technologies Inc., Elabscience Biotechnology Inc., Mayo Clinic Laboratories, Tonix Pharmaceuticals Holding Corp., Altona Diagnostics GmbH, Lansion Biotechnology Co. Ltd., Goldsite Diagnostics Inc., Chimerix Inc., Emcure Pharmaceuticals Ltd., VBI Vaccines Inc

North America was the largest region in the monkey pox treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monkey pox treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the monkey pox treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The monkey pox treatment market consists of sales of treatment products such as antiviral medications, vaccine administration devices, supportive care products, infection control supplies, and Reagents and assays for monkeypox research and diagnostic development. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Monkey Pox Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on monkey pox treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for monkey pox treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The monkey pox treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Prophylactic Vaccines; Therapeutics
• 2) By Dosage Forms: Solid; Liquid; Semi Solid
• 3) By Route Of Administration: Oral; Topical; Parenteral
• 4) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Prophylactic Vaccines: Vaccinia-Based Vaccines; Modified Vaccinia Ankara (MVA) Vaccines; Other Vaccines (Recombinant Vaccines)
• 2) By Therapeutics: Antiviral Agents (Tecovirimat, Brincidofovir); Immune Modulators; Supportive Care Treatments
• Companies Mentioned: Roche Holding AG; Merck & Co. Inc.; Sanofi S.A.; Gilead Sciences Inc.; BioNTech SE
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Monkey Pox Treatment Market Characteristics

3. Monkey Pox Treatment Market Trends And Strategies

4. Monkey Pox Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Monkey Pox Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Monkey Pox Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Monkey Pox Treatment Market Growth Rate Analysis
• 5.4. Global Monkey Pox Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Monkey Pox Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Monkey Pox Treatment Total Addressable Market (TAM)

6. Monkey Pox Treatment Market Segmentation

• 6.1. Global Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prophylactic Vaccines
• Therapeutics
• 6.2. Global Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Solid
• Liquid
• Semi Solid
• 6.3. Global Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Topical
• Parenteral
• 6.4. Global Monkey Pox Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• 6.5. Global Monkey Pox Treatment Market, Sub-Segmentation Of Prophylactic Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaccinia-Based Vaccines
• Modified Vaccinia Ankara (MVA) Vaccines
• Other Vaccines (Recombinant Vaccines)
• 6.6. Global Monkey Pox Treatment Market, Sub-Segmentation Of Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antiviral Agents (Tecovirimat, Brincidofovir)
• Immune Modulators
• Supportive Care Treatments

7. Monkey Pox Treatment Market Regional And Country Analysis

• 7.1. Global Monkey Pox Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Monkey Pox Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Monkey Pox Treatment Market

• 8.1. Asia-Pacific Monkey Pox Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Monkey Pox Treatment Market

• 9.1. China Monkey Pox Treatment Market Overview
• 9.2. China Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Monkey Pox Treatment Market

• 10.1. India Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Monkey Pox Treatment Market

• 11.1. Japan Monkey Pox Treatment Market Overview
• 11.2. Japan Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Monkey Pox Treatment Market

• 12.1. Australia Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Monkey Pox Treatment Market

• 13.1. Indonesia Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Monkey Pox Treatment Market

• 14.1. South Korea Monkey Pox Treatment Market Overview
• 14.2. South Korea Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Monkey Pox Treatment Market

• 15.1. Western Europe Monkey Pox Treatment Market Overview
• 15.2. Western Europe Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Monkey Pox Treatment Market

• 16.1. UK Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Monkey Pox Treatment Market

• 17.1. Germany Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Monkey Pox Treatment Market

• 18.1. France Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Monkey Pox Treatment Market

• 19.1. Italy Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Monkey Pox Treatment Market

• 20.1. Spain Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Monkey Pox Treatment Market

• 21.1. Eastern Europe Monkey Pox Treatment Market Overview
• 21.2. Eastern Europe Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Monkey Pox Treatment Market

• 22.1. Russia Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Monkey Pox Treatment Market

• 23.1. North America Monkey Pox Treatment Market Overview
• 23.2. North America Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Monkey Pox Treatment Market

• 24.1. USA Monkey Pox Treatment Market Overview
• 24.2. USA Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Monkey Pox Treatment Market

• 25.1. Canada Monkey Pox Treatment Market Overview
• 25.2. Canada Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Monkey Pox Treatment Market

• 26.1. South America Monkey Pox Treatment Market Overview
• 26.2. South America Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Monkey Pox Treatment Market

• 27.1. Brazil Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Monkey Pox Treatment Market

• 28.1. Middle East Monkey Pox Treatment Market Overview
• 28.2. Middle East Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Monkey Pox Treatment Market

• 29.1. Africa Monkey Pox Treatment Market Overview
• 29.2. Africa Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Monkey Pox Treatment Market Competitive Landscape And Company Profiles

• 30.1. Monkey Pox Treatment Market Competitive Landscape
• 30.2. Monkey Pox Treatment Market Company Profiles
  • 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. BioNTech SE Overview, Products and Services, Strategy and Financial Analysis

31. Monkey Pox Treatment Market Other Major And Innovative Companies

• 31.1. Moderna Inc.
• 31.2. Quest Diagnostics Incorporated
• 31.3. Novavax Inc.
• 31.4. Laboratory Corporation of America Holdings
• 31.5. Emergent BioSolutions Inc.
• 31.6. Bavarian Nordic A/S
• 31.7. Aegis Sciences Corporation
• 31.8. Daan Gene Co. Ltd.
• 31.9. Sansure Biotech Inc.
• 31.10. SIGA Technologies Inc.
• 31.11. Elabscience Biotechnology Inc.
• 31.12. Mayo Clinic Laboratories
• 31.13. Tonix Pharmaceuticals Holding Corp.
• 31.14. Altona Diagnostics GmbH
• 31.15. Lansion Biotechnology Co. Ltd.

32. Global Monkey Pox Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Monkey Pox Treatment Market

34. Recent Developments In The Monkey Pox Treatment Market

35. Monkey Pox Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Monkey Pox Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Monkey Pox Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Monkey Pox Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer